Venkataraman Sriram

Venture Investor/General Partner at RVL Pharmaceuticals plc; Director, 10% owner at OPTN; Director, 10% owner at LNTH

Sold, on record
$131M
Dollars the filings state
Form 4 sales
4
Latest Nov 25, 2019
Form 144 notices
2
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
4
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale LNTHUnusual
    Nov 21, 2016 2016

    Sold 2.5M shares at $9.00 ($22.5M)

    Venkataraman Sriram, Director, 10% owner

    Sold 36.9% of holdings ($61M position)4.3M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale LNTHUnusual
    Mar 17, 2017 +116 days

    Sold 3M shares at $12.20 ($36.6M)

    Venkataraman Sriram, Director, 10% owner

    Sold 46.6% of holdings ($78.6M position)3.4M shares leftFiling

  3. 3 Form 4 sale OPTNUnusual
    Jun 11, 2018 +451 days

    Sold 2.9M shares at $20.92 ($60.1M)

    Venkataraman Sriram, Director, 10% owner

    Sold 76.6% of holdings ($78.5M position)878,757 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale OPTNUnusual
    Nov 25, 2019 +532 days

    Sold 1.3M shares at $9.17 ($11.5M)

    Venkataraman Sriram, Director, 10% owner

    Sold 60.7% of holdings ($18.9M position)807,995 shares leftFiling

  5. 5 Form 144 notice RVL Pharmaceuticals plcNotice
    Aug 24, 2023 +1368 days

    Filed to sell 140,767 shares ($20k)

    Venkataraman Sriram, Venture Investor/General Partner

    No 10b5-1 planFirst sale on recordFiling

  6. 6 Form 144 notice RVL Pharmaceuticals plcNotice
    Aug 30, 2023 +6 days

    Filed to sell 160,078 shares ($16k)

    Venkataraman Sriram, Venture Investor/General Partner

    No 10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Venkataraman Sriram
Source
Aug 30, 2023Aug 30, 2023RVL Pharmaceuticals plcVenture Investor/General PartnerForm 144 notice160,078$16kNoticeSEC
Aug 24, 2023Aug 24, 2023RVL Pharmaceuticals plcVenture Investor/General PartnerForm 144 notice140,767$20kNoticeSEC
Nov 25, 2019Nov 26, 2019OPTNDirector, 10% ownerForm 4 sale1.3M$11.5M60.7%UnusualSEC
Jun 11, 2018Jun 13, 2018OPTNDirector, 10% ownerForm 4 sale2.9M$60.1M76.6%UnusualSEC
Mar 17, 2017Mar 21, 2017LNTHDirector, 10% ownerForm 4 sale3M$36.6M46.6%UnusualSEC
Nov 21, 2016Nov 23, 2016LNTHDirector, 10% ownerForm 4 sale2.5M$22.5M36.9%UnusualSEC